NCT00036504View on ClinicalTrials.gov

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

August 31, 2002

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Insulin Lispro low mixture

Trial Locations (13)

Unknown

La Jolla

Walnut Creek

New Britain

Longwood

Atlanta

Fayetteville

Boise

Springfield

Mount Laurel

New Brunswick

Syracuse

Chattanooga

Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00036504 - Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin | Biotech Hunter | Biotech Hunter